Biofil Chemicals Files SEBI Certificate for Q3 FY26

Biofil Chemicals & Pharmaceuticals Limited has submitted a confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate pertains to t...

Biofil Chemicals & Pharmaceuticals Limited has submitted a confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate pertains to the quarter ended December 31, 2025. The company received this confirmation from its Registrar and Share Transfer Agent, Ankit Consultancy Private Limited. Ankit Consultancy Private Limited confirmed that securities received from depository participants for dematerialization during the specified quarter were processed and listed on the stock exchanges. They also confirmed that the security certificates received for dematerialization were verified, cancelled, and the depositories were substituted as the registered owners within the stipulated 15-day period. The certificate is for the company's reference and further needful actions by the stock exchanges. The company's registered office is located in Indore, Madhya Pradesh.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Biofil Chemicals & Pharmaceuticals Limited in the news today?

Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) is in the news due to the announcement is a routine compliance filing and does not contain any information that would positively or negatively impact the company's stock or business operations.

SEBI Compliance FilingsShareholding Pattern
Biofil Chemicals & Pharmaceuticals LimitedBIOFILCHEMhttps://prysm.fi/v2/analyze/BIOFILCHEM

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Biofil Chemicals Files SEBI Certificate for Q3 FY26

January 2, 2026, 07:48 AM

AI Sentiment Analysis

Top Queries to Ask About Biofil Chemicals & Pharmaceuticals Limited

More Details on This News

Biofil Chemicals & Pharmaceuticals Limited has submitted a confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate pertains to the quarter ended December 31, 2025. The company received this confirmation from its Registrar and Share Transfer Agent, Ankit Consultancy Private Limited.

Ankit Consultancy Private Limited confirmed that securities received from depository participants for dematerialization during the specified quarter were processed and listed on the stock exchanges. They also confirmed that the security certificates received for dematerialization were verified, cancelled, and the depositories were substituted as the registered owners within the stipulated 15-day period.

The certificate is for the company's reference and further needful actions by the stock exchanges. The company's registered office is located in Indore, Madhya Pradesh.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Biofil Chemicals & Pharmaceuticals Limited

Discover more trending news on Prysm

View All